Your browser doesn't support javascript.
loading
Cost-Effectiveness of Ivacaftor Therapy for Treatment of Cystic Fibrosis Patients With the G551D Gating Mutation.
Wherry, Kael; Williamson, Ian; Chapman, Richard H; Kuntz, Karen M.
Affiliation
  • Wherry K; Division of Health Policy and Management, University of Minnesota, School of Public Health, Minneapolis, MN, USA. Electronic address: wher0013@umn.edu.
  • Williamson I; Division of Health Policy and Management, University of Minnesota, School of Public Health, Minneapolis, MN, USA.
  • Chapman RH; Institute for Clinical and Economic Review, Boston, MA, USA.
  • Kuntz KM; Division of Health Policy and Management, University of Minnesota, School of Public Health, Minneapolis, MN, USA.
Value Health ; 23(10): 1332-1339, 2020 10.
Article in En | MEDLINE | ID: mdl-33032777
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Health Care Costs / Quinolones / Cystic Fibrosis / Chloride Channel Agonists / Aminophenols Type of study: Health_economic_evaluation / Prognostic_studies Aspects: Patient_preference Limits: Female / Humans / Male Language: En Journal: Value Health Journal subject: FARMACOLOGIA Year: 2020 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Health Care Costs / Quinolones / Cystic Fibrosis / Chloride Channel Agonists / Aminophenols Type of study: Health_economic_evaluation / Prognostic_studies Aspects: Patient_preference Limits: Female / Humans / Male Language: En Journal: Value Health Journal subject: FARMACOLOGIA Year: 2020 Document type: Article Country of publication: Estados Unidos